KRYS CIK: 1711279

Krystal Biotech, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
–
FY23:
–
FY24:
–
FY25:
366
(positive)
Change from FY21 to FY25
millions USD
FY21:
−68.3
FY22:
−145
FY23:
−110
FY24:
65.7
FY25:
138
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.2
FY22:
–
FY23:
–
FY24:
–
FY25:
168
(positive)
Change from FY21 to FY25
millions USD
FY21:
−69.6
FY22:
−140
FY23:
12.9
FY24:
95.4
FY25:
189
(positive)
Change from FY21 to FY25
millions USD
FY21:
−69.6
FY22:
−140
FY23:
10.9
FY24:
89.2
FY25:
205

All amounts in millions USD Data sources:SEC EDGARTwelve Data